Company Name or Ticker Symbol
Search for other Categories

Coherus Biosciences, Inc.  (CHRS)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs

CHRS's Revenue Year on Year Growth by Quarter and Year

Coherus Biosciences,'s Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
CHRS Revenue (in millions $) FY 2016 FY 2015 FY 2014 FY 2013
IV Quarter December - 10.20 -46.09 0.00
III Quarter September 162.84 7.17 16.05 0.00
II Quarter June 14.07 6.87 0.00 0.00
I Quarter March 12.36 5.81 0.00 0.00
FY   189.27 30.05 -30.04 -

Financial Statements
Coherus Biosciences,'s third quarter 2016 Revenue $ 162.84 millions CHRS's Income Statement
Coherus Biosciences,'s third quarter 2015 Revenue $ 7.17 millions Quarterly CHRS's Income Statement
CHRS's Growth by Division See CHRS's Growth by Segment

CHRS Revenue ( Y/Y Growth %) 2016
2015 2014 2013
IV Quarter December - - - -
III Quarter September 2171.06 % -55.33 % - -
II Quarter June 104.8 % - - -
I Quarter March 112.74 % - - -
FY   - - - -

CHRS Revenue Growth Comment
Coherus Biosciences, Inc. achieved in the third quarter, above Company average Revenue surge of 2171.06% year on year, to $ 162.84 millions.

According to the results reported in the third quarter, Coherus Biosciences, Inc. achieved the best Revenue growth in Biotechnology & Drugs industry. While Coherus Biosciences, Inc.' s Revenue doubling of 2171.06% ranks overall at the positon no. 39 in the third quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #9
S&P 500 #39
Revenue Y/Y Growth Statistics
High Average Low
2172.01 % 583.57 % -55.35 %
(Sep 30 2016)   (Sep 30 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CHRS's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CHRS's Competitors
Revenue Growth for Coherus Biosciences,'s Suppliers
Revenue Growth for CHRS's Customers

You may also want to know
CHRS's Annual Growth Rates CHRS's Profitability Ratios CHRS's Asset Turnover Ratio CHRS's Dividend Growth
CHRS's Roe CHRS's Valuation Ratios CHRS's Financial Strength Ratios CHRS's Dividend Payout Ratio
CHRS's Roa CHRS's Inventory Turnover Ratio CHRS's Growth Rates CHRS's Dividend Comparisons

Companies with similar Revenue doubling for the quarter ending Sep 30 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2016
Progenics Pharmaceuticals Inc  3,757.45 %$ 3,757.450 millions
Hci Viocare  2,541.83 %$ 2,541.827 millions
Pfenex Inc.  2,273.55 %$ 2,273.554 millions
Coherus Biosciences, Inc.  2,172.01 %$ 2,172.011 millions
Epizyme, Inc.  1,739.11 %$ 1,739.106 millions
Idera Pharmaceuticals, Inc.  1,515.00 %$ 1,515.000 millions
Juno Therapeutics, Inc.  1,200.00 %$ 1,200.000 millions
Guided Therapeutics Inc  1,087.50 %$ 1,087.500 millions

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
SFS's Profile
Stock Price
SFS's Financials
SFS's Expectations
Business Description
Charts & Quotes
SFS's News
SFS's Competitors
Customers & Markets
Economic Indicators
SFS's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com